Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies
Portfolio Pulse from
Teknova and Pluristyx have announced a collaboration where Teknova will become the exclusive manufacturer and distributor of Pluristyx's PluriFreeze™ Cryopreservation System, aimed at enhancing the production of next-generation cell therapies.
March 11, 2025 | 11:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Teknova has entered into a partnership with Pluristyx to exclusively manufacture and distribute the PluriFreeze™ Cryopreservation System, which could enhance Teknova's role in the cell therapy market.
The exclusive manufacturing and distribution rights for a novel cryopreservation system could position Teknova as a key player in the cell therapy market, likely leading to increased revenue and market presence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90